Aerovate Therapeutics
AVTE
#9173
Rank
โ‚ฌ70.04 M
Marketcap
2,42ย โ‚ฌ
Share price
0.00%
Change (1 day)
-87.23%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ10.02 Million

According to Aerovate Therapeutics's latest financial reports the company's total liabilities are โ‚ฌ10.02 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ7.97 M206.8%
2021-12-31โ‚ฌ2.6 M-82.29%
2020-12-31โ‚ฌ14.68 M129.81%
2019-12-31โ‚ฌ6.38 M